BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Moberg Derma Acquires Credit Facility of 50 Msek


8/16/2010 10:02:54 AM

16 Aug, 2010 Moberg Derma has acquired a credit facility totaling SEK 50 million. The agreement runs for two years. The facility will be used to finance day-to-day operations. The facility may be drawn on as required from 1 January 2011.

The lender is Shejk Mohammed H. Al Amoudi who is also a shareholder in Moberg Derma, with a 2.5% holding. Västra Hamnen Fondkondkommission AB has acted as consultant to Shejk Mohammed H. Al Amoudi.

“Through the credit facility, we have secured a further supply of capital that will enable us without compromise to continue our work of commercializing our medical products and maintain the development of the company’s important pharmaceutical projects”, comments Peter Wolpert, CEO, Moberg Derma.

During the year, Moberg Derma will launch two products. Emtrix™, which is used to treat nail diseases, and the Kaprolac® range of products, which are used for scalp and skin disorders such as eczema and dry skin.

Contact Moberg Derma Peter Wolpert, President and CEO Mobile: +46 70 - 735 71 35 E-mail: peter.wolpert@mobergderma.se

About Moberg Derma

Moberg Derma AB, Stockholm, Sweden, develops and commercializes patented medical products for the treatment of skin disorders. The company focuses on innovative products based on proven compounds. Moberg Derma outlicenses product rights to partners and distributors while maintaining certain promotion rights. The company began operations at the Karolinska Institute in 2006. The principal owners are Östersjöstiftelsen (the Baltic Sea Foundation), private investors and management. For further information, please visit: www.mobergderma.se



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES